Pricing Log in Create free account

Cocrystal Pharma, Inc. (COCP) vs Estrella Immunopharma, Inc. (ESLA)

Cocrystal Pharma, Inc. and Estrella Immunopharma, Inc. are both Biotechnology companies. Cocrystal Pharma, Inc. and Estrella Immunopharma, Inc. are of similar size ($19.3M and $17.8M). Estrella Immunopharma, Inc. has the higher net margin (0.00% vs −747.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Estrella Immunopharma, Inc. leads on 6 and Cocrystal Pharma, Inc. on 4.

Valuation

Metric COCP ESLA Biotechnology median
P/E n/m n/m 10.60
P/S 10.69 n/m 9.40
P/B 13.60 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 9.00 n/m 9.02
Earnings yield (73.79%) (65.92%) (32.88%)
Free cash flow yield (56.09%) (58.98%) (23.13%)

Profitability

Metric COCP ESLA Biotechnology median
Gross margin 9.10% — 68.51%
Operating margin (760.72%) 0.00% 0.00%
Net margin (747.78%) 0.00% 0.00%
Free cash flow margin (598.50%) 0.00% 0.00%
Return on equity (311.68%) 148.05% (51.96%)
Return on assets (151.10%) (416.74%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric COCP ESLA Biotechnology median
Revenue growth (TTM) (30.38%) — 6.76%
EPS growth (last fiscal year) 54.65% (188.78%) 29.88%
Revenue growth, 5-year CAGR (33.30%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COCP ESLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.24 0.20 4.97
Net debt to EBITDA 0.82 0.11 1.01

Dividend

Metric COCP ESLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COCP ESLA Biotechnology median
Market cap 19.27m 17.84m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack